Medically reviewed by Christopher Lee, MD Treatment for ATTR-CM has historically been symptom management. However, until 2019, the United States Food and Drug Administration (FDA) did not approve any ...

犬利什曼病（Canine leishmaniosis）是由婴儿利什曼原虫（Leishmania infantum）引发的慢性寄生虫病，通过白蛉叮咬传播，在地中海地区流行。当前临床首选治疗方案是甲葡胺锑（meglumine antimoniate）与别嘌呤醇（allopurinol）联用，但两种药物已知可能引发肾功能损伤、尿酸代谢异常等副作用。更令人担忧的是 ...

Results of an online survey posted on the American Association of Zoo Veterinarians listserv examined the patterns of analgesic medication and pain management modalities used for captive giraffe and ...

Pfizer reckons it will make a whopping $22 billion in sales of its oral COVID-19 antiviral Paxlovid in 2022, with another $32 billion from its BioNTech-partnered coronavirus vaccine Comirnaty. The ...

Pfizer’s first application is for a 20 mg capsule formulation of tafamidis meglumine, which has a proposed dose of 80 mg per day and is due for a speedy FDA verdict in July.